## Top 500 inclusion/exclusion criteria:
[' pregnancy',
 ' study',
 ' not specified',
 ' screening',
 ' treatment',
 ' ',
 ' informed consent',
 ' months',
 ' the study',
 ' written informed consent',
 ' investigator',
 ' patient characteristics',
 ' 5',
 'disease characteristics',
 ' disease',
 ' prior concurrent therapy',
 ' 5 x uln',
 ' other',
 ' pregnant women',
 ' therapy',
 ' enrollment',
 ' surgery',
 ' none',
 ' signed informed consent',
 ' 0',
 ' see disease characteristics',
 ' chemotherapy',
 ' pregnant or lactating women',
 ' consent',
 ' criteria',
 ' not pregnant or nursing',
 ' 0 mg/dl',
 ' 1',
 ' 5 mg/dl',
 '  may apply',
 ' negative pregnancy test',
 ' pregnancy or lactation',
 ' age',
 ' excluded',
 ' key ',
 ' randomization',
 ' 0 g/dl',
 ' protocol',
 ' performance status',
 'key',
 ' radiotherapy',
 ' administration',
 ' visit',
 ' pregnancy or breastfeeding',
 ' or',
 ' hepatic',
 ' renal',
 ' requirements',
 ' participation',
 ' period',
 ' age ≥ 18 years',
 ' pregnant',
 ' cancer',
 ' procedures',
 ' in the study',
 ' pregnant or breastfeeding women',
 ' trial',
 ' diabetes',
 ' hematopoietic',
 ' life expectancy',
 ' pregnant or breastfeeding',
 ' uncontrolled intercurrent illness including but not limited to ongoing or active',
 ' 5 times uln',
 ' endocrine therapy',
 ' biologic therapy',
 ' allowed',
 ' medication',
 ' fertile patients must use effective contraception',
 ' contraception',
 ' total bilirubin ≤',
 ' uncontrolled hypertension',
 ' infection',
 ' diabetes mellitus',
 ' ability to understand and the willingness to sign a written informed consent document',
 ' years',
 ' registration',
 ' smoking',
 ' serum creatinine ≤',
 ' screening visit',
 ' 2',
 ' this study',
 ' following',
 ' creatinine ≤',
 ' entry',
 ' breastfeeding',
 ' eligible',
 ' study requirements',
 ' procedure',
 ' cardiovascular',
 ' history of allergic reactions attributed to compounds of similar chemical or biologic',
 ' other protocoldefined /',
 ' english speaking',
 ' hemoglobin ≥',
 ' hypertension',
 ' infection symptomatic congestive heart failure unstable angina pectoris cardiac',
 ' patients',
 ' duration of the study',
 'age ≥ 18 years',
 ' drug',
 ' bilirubin ≤',
 ' age > 18 years',
 ' etc',
 ' weeks',
 ' medications',
 ' claustrophobia',
 ' disorder',
 ' during the study',
 ' prisoners',
 ' study drug',
 ' 5 to',
 ' able to provide informed consent',
 ' pregnant or lactating',
 ' of the study',
 ' malignancy',
 ' 0 to',
 ' 0 and',
 ' age < 18 years',
 ' 5 x',
 ' dementia',
 ' intervention',
 ' study entry',
 ' pregnancy or breast feeding',
 ' 18 years of age or older',
 ' prior to screening',
 ' 18 and over',
 ' days',
 ' inability to provide informed consent',
 ' arrhythmia or psychiatric illness/social situations that would limit compliance with',
 ' 5 times upper limit of normal uln',
 ' total bilirubin =<',
 ' syndrome',
 ' study treatment',
 ' smokers',
 ' women who are pregnant or breastfeeding',
 ' pregnant or lactating females',
 ' female',
 ' nonenglish speaking',
 ' participation in the study',
 ' pregnant or nursing women',
 ' baseline',
 ' and',
 ' disorders',
 ' age ≥18 years',
 ' the investigator',
 ' male or female',
 ' vaccination',
 ' following criteria',
 ' unstable angina',
 ' additional ',
 ' transplantation',
 ' active infection',
 ' participate in the study',
 ' patient refusal',
 ' examination',
 ' able to give informed consent',
 ' adequate organ function',
 ' drugs',
 ' creatinine no greater than',
 ' 5 g/dl',
 ' additional',
 ' at least 18 years of age',
 ' ecog performance status 02',
 ' epilepsy',
 ' 5%',
 ' physician',
 ' normal',
 ' study period',
 ' measurable disease',
 ' congestive heart failure',
 ' age 18 years or older',
 ' inability to give informed consent',
 ' in this study',
 ' diseases',
 ' prior to enrollment',
 '18 years of age or older',
 ' 4',
 ' guidelines',
 ' and ',
 ' 5 × uln',
 ' permitted',
 ' excipients',
 ' 3',
 ' bilirubin no greater than',
 ' assessment',
 ' coagulopathy',
 ' required',
 ' creatinine <',
 'age > 18 years',
 ' signed written informed consent',
 ' absolute neutrophil count anc ≥',
 ' pregnant patients',
 ' ecog 02',
 ' serum creatinine >',
 '  apply',
 'written informed consent',
 ' metastases',
 'signed informed consent',
 ' total bilirubin <',
 ' prior medication',
 ' metastatic disease',
 ' year',
 'female',
 ' potential participation in a clinical trial',
 ' emergency surgery',
 ' hiv infection',
 ' hiv negative',
 ' pregnant or nursing',
 ' women of childbearing potential and men must agree to use adequate contraception',
 ' pulmonary',
 ' assessments',
 ' the above information is not intended to contain all considerations relevant to a patients',
 ' cognitive impairment',
 ' dosing',
 ' male',
 ' 5 x upper limit of normal uln',
 ' study;',
 ' uln',
 ' serum creatinine <',
 ' 5 x 109/l',
 ' inflammatory bowel disease',
 ' control',
 ' the trial',
 ' unable to provide informed consent',
 ' 5 and',
 ' form',
 ' potential',
 ' patient',
 ' age <18 years',
 ' not pregnant',
 ' life expectancy of at least 3 months',
 ' results',
 ' liver disease',
 ' ability to provide informed consent',
 ' 18 years or older',
 ' platelet count at least 100000/mm^3',
 ' main ',
 ' pregnant or lactating women;',
 ' product',
 ' age 18',
 ' englishspeaking',
 ' corticosteroids',
 ' uncontrolled diabetes',
 ' body mass index bmi of',
 ' participate',
 ' pregnancy;',
 ' pregnant woman',
 ' test',
 ' screening;',
 ' conditions',
 ' day',
 ' note other protocol defined /',
 ' at screening',
 ' coexisting condition',
 'main',
 ' asthma',
 ' heart failure',
 ' diagnosis',
 ' pregnant or breast feeding',
 ' 0 x uln',
 ' ecog performance status 01',
 ' type 1 diabetes',
 ' 0%',
 ' evaluation',
 ' rheumatoid arthritis',
 ' consent form',
 ' provide written informed consent',
 ' cardiovascular disease',
 ' has an active infection requiring systemic therapy',
 ' function',
 ' signed informed consent form',
 ' has a history or current evidence of any condition therapy or laboratory abnormality',
 ' age >18 years',
 ' eastern cooperative oncology group ecog performance status of 0 or 1',
 ' 5 times upper limit of normal',
 ' failure',
 ' bilirubin <',
 ' ability to give informed consent',
 ' subject',
 ' creatinine =<',
 ' 1 criteria',
 ' unstable angina pectoris',
 'no eligibility criteria',
 ' criterion',
 ' cooperation with the requirements of the trial',
 ' pregnancy and lactation',
 ' has known psychiatric or substance abuse disorders that would interfere with',
 ' drug abuse',
 ' visits',
 ' study participation',
 ' acceptable',
 ' 0 kg/m2',
 ' refusal to participate',
 'age 18 years or older',
 ' unable to give informed consent',
 'age ≥18 years',
 '18 years or older',
 ' pregnant or breastfeeding woman',
 ' 5 uln',
 ' serum creatinine =<',
 ' included',
 ' hiv positive',
 ' 5 x upper limit of normal',
 ' symptoms',
 ' transplant',
 ' able to provide written informed consent',
 ' myocardial infarction',
 ' renal failure',
 'male or female',
 ' carcinoma',
 ' platelet count ≥ 100000/mm^3',
 ' document',
 ' enrolment',
 ' than',
 ' singleton pregnancy',
 ' alcohol or drug abuse',
 ' is pregnant or breastfeeding or expecting to conceive or father children within the',
 ' life expectancy of at least 12 weeks',
 ' ≤',
 ' mg/dl',
 ' pregnant and lactating women',
 ' the',
 ' study medication',
 ' e',
 ' fluent in english',
 ' inclusive',
 ' pacemaker',
 ' study procedures',
 ' prior to randomization',
 ' agents',
 ' women who are pregnant or lactating',
 ' condition',
 ' 5 times the upper limit of normal',
 ' followup',
 ' months prior to screening',
 ' to',
 ' month',
 ' autoimmune disease',
 ' hemoglobin >=',
 ' to screening',
 ' 5 x institutional upper limit of normal',
 ' history of seizures',
 ' life expectancy > 3 months',
 ' n/a',
 ' glaucoma',
 ' nonsmoker',
 ' ast and alt ≤',
 ' healthy volunteers',
 ' may apply',
 ' prior to study entry',
 ' concurrent medication',
 ' ecog performance status 0',
 ' bmi',
 ' classification',
 ' creatinine >',
 ' during the study period',
 ' admission',
 ' hemoglobin >',
 ' lactation',
 ' questionnaire',
 ' smoker',
 ' atrial fibrillation',
 ' no other concurrent investigational agents',
 ' stroke',
 ' healthy',
 ' device',
 ' pregnant females',
 ' investigational product',
 ' the protocol',
 ' testing',
 ' the following',
 ' course of the study',
 ' months;',
 ' 5 x 10^9/l',
 ' 7',
 ' pneumonitis',
 ' breast feeding',
 ' abnormalities',
 ' with use of disease modifying agents corticosteroids or immunosuppressive',
 ' arrhythmia',
 ' women',
 'male',
 ' hiv',
 ' the ',
 ' age less than 18 years',
 ' apply',
 ' refusal to participate in the study',
 'healthy',
 ' nonsmokers',
 ' regimen',
 ' treatment;',
 ' women of childbearing potential',
 'healthy volunteers',
 ' non',
 ' childbearing potential',
 ' body mass index bmi between',
 ' history',
 ' hemodynamic instability',
 ' 8',
 ' psychiatric disorders',
 ' substance abuse',
 ' age 18 or older',
 ' 6 months',
 ' replacement therapy for adrenal or pituitary insufficiency etc is not considered a',
 ' 6',
 ' general ',
 ' total bilirubin >',
 ' products',
 ' the subject to participate in the opinion of the treating investigator',
 ' 9',
 ' resection',
 ' control group',
 ' current pregnancy',
 ' life expectancy ≥ 3 months',
 ' participating in the study',
 ' dose of study drug',
 ' by the investigator',
 ' pregnant or lactating female',
 ' neurological disorders',
 ' informed consent signed',
 ' under 18 years of age',
 ' cardiogenic shock',
 ' clinical trial',
 ' informed consent form',
 ' alkaline phosphatase ≤',
 ' mental retardation',
 ' other protocoldefined ',
 ' psychiatric illness/social situations that would limit compliance with study',
 ' into the study',
 ' evidence or history of clinically significant hematological renal endocrine',
 ' >',
 ' hemoglobin ≥ 9 g/dl',
 ' for',
 ' positive pregnancy test',
 ' 0 mmol/l',
 ' psychosis',
 ' willing and able to provide written informed consent',
 'at least 18 years of age',
 ' participation for the full duration of the trial or is not in the best interest of',
 ' uncontrolled diabetes mellitus',
 'general',
 ' carcinoma in situ of the cervix',
 ' hours',
 ' system',
 ' inhibitors',
 ' females',
 ' antibodies',
 ' multiple pregnancy',
 ' greater than',
 ' throughout the study',
 ' serum bilirubin ≤',
 ' program',
 ' current or chronic history of liver disease or known hepatic or biliary abnormalities',
 ' limit of normal',
 ' vaccine',
 'informed consent',
 ' =<',
 ' hemoglobin <',
 ' the subject has participated in a clinical trial and has received an investigational',
 ' anemia',
 ' active tuberculosis',
 ' currently pregnant',
 ' hysterectomy',
 ' version',
 ' children',
 ' no concurrent radiotherapy',
 ' 5 times',
 ' immediately',
 ' hospital',
 ' participation in this study',
 ' dose',
 ' ml/min',
 ' schizophrenia',
 ' immunodeficiency',
 ' no informed consent',
 ' evaluations',
 ' drug or alcohol abuse',
 ' drugs replacement therapy eg thyroxine insulin or physiologic corticosteroid',
 'the',
 ' treatments',
 ' gastrointestinal hepatic renal respiratory cardiovascular metabolic',
 ' eye',
 ' active malignancy',
 ' stated willingness to comply with all study procedures and availability for the',
 ' determined by the investigator',
 ' other protocoldefined',
 ' section',
 ' eastern cooperative oncology group ecog performance status of 0 or',
 ' other severe acute or chronic medical or psychiatric condition or laboratory',
 ' cardiac arrhythmia',
 ' cirrhosis',
 ' pregnant or lactating woman',
 ' less than 18 years of age',
 ' uncontrolled infection',
 ' infections',
 ' hospitalization']
